Moreover, the recent discovery of the contribution of STAT3 activation in the transmission of intracellular signals of multiple cytokines promoting inflammation in fibrotic diseases (50), suggests that inhibition of USP21 can be potentially used as a therapeutic strategy to prevent the progression of pulmonary fibrosis. Here, USP21 is linked to pulmonary fibrosis.